reduce basal insulin when starting glp-1 receptor agonist agonists for individualized treatment of type 2 diabetes mellitus Cardiovascular outcomes after initiating GLP-1
Description
Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway
Figure 1 Biological characteristics of GLP-1 In the 1980s, a new glucagon-like peptide, produced from proglucagon cleavage, was discovered to stimulate insulin secretion (86)
Cai CX, Michalak SM, Stinnett SS, Muir KW, Fekrat S, Borkar DS
Slowing the gut brings nausea, constipation, and reflux
Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice
